JP2021512148A5 - - Google Patents

Info

Publication number
JP2021512148A5
JP2021512148A5 JP2020561572A JP2020561572A JP2021512148A5 JP 2021512148 A5 JP2021512148 A5 JP 2021512148A5 JP 2020561572 A JP2020561572 A JP 2020561572A JP 2020561572 A JP2020561572 A JP 2020561572A JP 2021512148 A5 JP2021512148 A5 JP 2021512148A5
Authority
JP
Japan
Prior art keywords
therapeutic agent
e4orf1
npc
sci
agent according
Prior art date
Application number
JP2020561572A
Other languages
English (en)
Japanese (ja)
Other versions
JP7391308B2 (ja
JP2021512148A (ja
JPWO2019144102A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/014497 external-priority patent/WO2019144102A1/en
Publication of JP2021512148A publication Critical patent/JP2021512148A/ja
Publication of JP2021512148A5 publication Critical patent/JP2021512148A5/ja
Publication of JPWO2019144102A5 publication Critical patent/JPWO2019144102A5/ja
Application granted granted Critical
Publication of JP7391308B2 publication Critical patent/JP7391308B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020561572A 2018-01-22 2019-01-22 脊髄損傷の治療のための組成物および方法 Active JP7391308B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862620269P 2018-01-22 2018-01-22
US62/620,269 2018-01-22
PCT/US2019/014497 WO2019144102A1 (en) 2018-01-22 2019-01-22 Compositions and methods for treatment of spinal cord injury

Publications (4)

Publication Number Publication Date
JP2021512148A JP2021512148A (ja) 2021-05-13
JP2021512148A5 true JP2021512148A5 (https=) 2022-02-24
JPWO2019144102A5 JPWO2019144102A5 (https=) 2022-02-24
JP7391308B2 JP7391308B2 (ja) 2023-12-05

Family

ID=67301897

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020561572A Active JP7391308B2 (ja) 2018-01-22 2019-01-22 脊髄損傷の治療のための組成物および方法

Country Status (7)

Country Link
US (1) US20210030810A1 (https=)
EP (1) EP3743085A4 (https=)
JP (1) JP7391308B2 (https=)
CN (1) CN111886016A (https=)
AU (1) AU2019209439A1 (https=)
CA (1) CA3089324A1 (https=)
WO (1) WO2019144102A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3512937B1 (en) 2016-09-13 2024-10-09 Angiocrine Bioscience, Inc. Blood-brain barrier comprising engineered endothelial cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008089448A2 (en) * 2007-01-19 2008-07-24 Cornell Presearch Foundation, Inc. Methods and compositions for promoting survival & proliferation of endothelial cells & stimulating angiogenesis
AU2015279552B2 (en) * 2014-06-27 2021-01-21 Angiocrine Bioscience, Inc. Neural cells expressing adenovirus E4ORF1, and methods of making and using the same
KR101675123B1 (ko) * 2014-06-27 2016-11-14 연세대학교 산학협력단 Psa-ncam-양성 신경전구세포를 유효성분으로 포함하는 허혈성 질환 또는 신경염증 질환 치료용 조성물
ES2815537T3 (es) * 2015-06-26 2021-03-30 S Biomedics Composición para el tratamiento de enfermedades isquémicas o trastornos inflamatorios neurogénicos, que contienen el secretoma de células progenitoras neurales como ingrediente activo
CN108291196B (zh) * 2015-07-20 2021-08-27 安吉克莱茵生物科学有限公司 表达ets转录因子的工程化的内皮细胞

Similar Documents

Publication Publication Date Title
KR20200143407A (ko) Cgrp를 억제하는데 사용하기 위한 신경독소
US12109181B2 (en) Lidocaine patch and methods of use thereof
JP2010523264A5 (https=)
ES2946262T3 (es) Lámina de liberación sostenida de fármaco para el tratamiento de la lesión nerviosa
US10907144B2 (en) Methods and systems for generation, use, and delivery of activated stem cells
JP2002532432A5 (https=)
CN107072716A (zh) 用于产生和使用活化的干细胞的方法和系统
JP2019521976A5 (https=)
EP1183047B1 (de) Proteinenthaltende pharmazeutische zubereitung
JP2020511548A (ja) 治療用のボツリヌス神経毒素
KR20180094889A (ko) 활성화된 줄기 세포의 생성, 사용, 및 전달을 위한 방법 및 시스템
DE60021360T2 (de) Vegf angiogenische wachstumsfaktoren zur behandlung von peripherer neuropathie
JP2016516071A (ja) 瘢痕形成を軽減するためのｓｄｆ−１の使用
Ren et al. Developing extracellular matrix technology to treat retinal or optic nerve injury
CN103705910A (zh) 一种齐考诺肽注射型皮下植入剂及其制备方法
JP2021512148A5 (https=)
JP2019526584A5 (https=)
CN1278184A (zh) 预防或治疗局部缺血性疾病的药剂
Ryabov et al. Collagen Implant and Mononuclear Cells of Umbilical Blood Allow the Restore of Movements of Hind Limbs after Removing the Site of Spinal Cord.
JPWO2019144102A5 (https=)
US20240189382A1 (en) Formula for inhibiting aging regeneration repair
RU2122844C1 (ru) Способ лечения герпетического кератита с изъязвлением
CN208243663U (zh) 一种作为血管支架外包的纳米药物缓释装置
JP5819734B2 (ja) ＴＧＦ−βスーパーファミリーメンバー含有タンパク質の最小に侵襲性の全身送達のための組成物および方法
JP6977979B2 (ja) 神経損傷治療又は予防用医薬